CN104586776B — 以硼替佐米为活性成分的制剂及其制备方法
Assigned to Shanghai Haini Pharm Co Ltd Yangzijiang Pharm Group · Expires 2017-05-17 · 9y expired
What this patent protects
一种以硼替佐米为活性成分的制剂,含有硼替佐米、增溶剂和赋型剂,其中赋形剂选自于甘露醇、低分子右旋糖酐、乳糖、山梨醇和葡萄糖之一种或几种。本发明提供的以硼替佐米为活性成分的制剂,具有复溶性好,总杂质小于0.4%,解决硼替佐米制备过程中溶解速度慢的问题,提高硼替佐米制剂的稳定性,并将有关物质降低至较低水平(40℃加速3个月后总相关物质小于0.7%)。
USPTO Abstract
一种以硼替佐米为活性成分的制剂,含有硼替佐米、增溶剂和赋型剂,其中赋形剂选自于甘露醇、低分子右旋糖酐、乳糖、山梨醇和葡萄糖之一种或几种。本发明提供的以硼替佐米为活性成分的制剂,具有复溶性好,总杂质小于0.4%,解决硼替佐米制备过程中溶解速度慢的问题,提高硼替佐米制剂的稳定性,并将有关物质降低至较低水平(40℃加速3个月后总相关物质小于0.7%)。
Drugs covered by this patent
- Velcade (bortezomib) · Shilpa
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.